Ling Xiao

2 articles

Four Entities Report Beneficial Ownership of BioNexus Gene Lab Corp Shares

Fidelion Diagnostics and three other parties filed a Schedule 13G disclosing 13.4% beneficial ownership of BioNexus Gene Lab Corp, with Fidelion retaining sole voting power over the shares.

Stock Titan · 2026-10-22 22:11

BioNexus Gene Lab Files Initial Beneficial Ownership Statement for Fidelion Diagnostics Pte. Ltd

BioNexus Gene Lab Corp filed a Form 3 statement revealing Fidelion Diagnostics Pte. Ltd holds over 5% of common shares. The filing identifies Fidelion as a greater-than-5% holder with 392,329 shares a

Bitget · 2026-08-07 12:40